Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis
Keywords: 
Inflamatory MRI
Mesenchymal stem cells
Autologous
Issue Date: 
2014
Publisher: 
Public Library of Science
ISSN: 
1932-6203
Citation: 
Llufriu S, Sepúlveda M, Blanco Y, Marín P, Moreno B, Berenguer J, et al. Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis. PLoS One. 2014 Dec 1;9(12):e113936.
Abstract
Bone-marrow-MSCs are safe and may reduce inflammatory MRI parameters supporting their immunomodulatory properties. ClinicalTrials.gov NCT01228266.

Files in This Item:
Thumbnail
File
pone.0113936.pdf
Description
Size
655.82 kB
Format
Adobe PDF


Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.